Lunch Meeting with IceCure Medical Execs.
イスラエルのIceCure Medical社、CEOのMr Eyal Shamir 、Vice PresidentのMr Shay Levav、同僚の嶋内先生と。
日本乳癌学会で2度目のランチョンセミナーを行うために来日。
乳がんの凍結療法を20年近くやってこられた先駆的企業です。私も数年前に関連する論文を執筆しました。
銀座にてランチミーティング。
乳がんの凍結療法は、高い治癒率と術後の審美的な優位性が証明されています。日本では保険適応外ですが、こういう素晴らしい治療法がもっと広まっていくといいのになあと思います。
会場は、カルボナーラで有名なフィオレンツァでした。
===========
With Israel-based IceCure Medical’s CEO Mr. Eyal Shamir, Vice President Mr. Shay Levav, and my colleague Dr. Shimauchi.
They have come to Japan to give their second luncheon seminar at the annual meeting of the Japan Breast Cancer Society.
IceCure Medical is a pioneering company that has spent nearly two decades advancing cryoablation therapy for breast cancer—a field in which I, too, published a related paper a few years ago.
We held a lunch meeting in Ginza.
Cryoablation for breast cancer has already proven both a high cure rate and clear postoperative cosmetic advantages.
Although it is not yet covered by public insurance in Japan, I hope this excellent treatment will become more widely adopted.
The venue was Fiorenza, a restaurant famous for its carbonara.
IceCure Medical, web site:
